United States Digital Therapeutics Market Trends & Forecast | Major Players 2025 - Alliance, Noom, Inc., Omada Health, Inc.

"The global digital therapeutics market size reached US$ 6.84Billion in 2024 and is expected to reach US$ 39.52 Billion by 2033, growing at a CAGR of 21.6%during the forecast period 2025-2033." As per DataM intelligence research report

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/digital-therapeutics-market?sp

United States: Recent Industry Developments

✅ In September 2025, Pear Therapeutics launched a next-generation prescription digital therapeutic platform for chronic insomnia and depression, integrating AI-driven behavioral analysis and remote patient monitoring for personalized care.

✅ In August 2025, Akili Interactive completed a $60 million Series C funding round to scale its digital therapeutics solutions for ADHD and cognitive disorders, supporting expansion into hospital systems and telehealth platforms.

✅ In July 2025, Omada Health acquired Vida Health, a digital health company specializing in chronic disease management, enhancing Omada's capabilities in scalable behavioral health interventions and digital therapeutics offerings.

✅ In June 2025, Propeller Health launched a new AI-based asthma and COPD management platform, providing real-time insights and predictive analytics for patients and healthcare providers to optimize treatment adherence and outcomes.

Japan: Recent Industry Developments

✅ In September 2025, Fujitsu Limited introduced a digital therapeutics platform targeting metabolic syndrome and lifestyle-related diseases, integrating wearable data, AI coaching, and telemedicine capabilities for personalized interventions.

✅ In August 2025, M3, Inc. invested in CureApp, a Japanese digital therapeutics developer, to expand its offerings for smoking cessation and chronic disease management using smartphone-based therapeutic solutions.

✅ In July 2025, Sony Corporation partnered with Healios KK to develop digital therapeutics for cognitive decline, combining AI-driven cognitive training programs with remote patient monitoring technologies.

✅ In June 2025, Takeda Pharmaceutical launched a pilot program for digital therapeutics in Japan for hypertension management, integrating app-based behavior modification with patient data tracking to support improved treatment outcomes.

Digital Therapeutics Market: Drivers

The digital therapeutics market is experiencing rapid growth as healthcare providers and patients increasingly adopt technology-driven solutions for the prevention, management, and treatment of chronic and lifestyle-related diseases. Digital therapeutics leverage software-based interventions, including mobile apps, wearable devices, and virtual platforms, to deliver evidence-based clinical outcomes for conditions such as diabetes, cardiovascular diseases, mental health disorders, and obesity. Rising demand for personalized and remote healthcare solutions is driving adoption, especially in the wake of telemedicine expansion and growing patient engagement in self-care. Regulatory recognition and reimbursement support for clinically validated digital therapeutics are further boosting market confidence.

Technological advancements in artificial intelligence, machine learning, and real-time data analytics are enhancing the precision, effectiveness, and customization of digital therapeutic programs. Integration with electronic health records (EHRs) and remote patient monitoring systems is enabling seamless care coordination and outcome tracking. Growing awareness of preventive healthcare, lifestyle management, and behavioral interventions is encouraging patients to adopt digital therapeutics as part of routine care. Expansion of healthcare infrastructure, rising smartphone penetration, and increasing acceptance of mobile health solutions in emerging markets are further supporting adoption. Collectively, these factors are positioning the digital therapeutics market for sustained growth as technology becomes central to modern, patient-centric healthcare delivery.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/digital-therapeutics-market?sp

Digital Therapeutics Market: Major Players

Alliance, Noom, Inc., Omada Health, Inc., Q4, Inc., Teladoc Health, Inc., Akili, Inc., Kaia Health,Welldoc, Inc., Hinge Health, Inc., and Click Therapeutics, Inc., among others.

Segment Covered in the Digital Therapeutics Market:

➥ By Product Type: Software, Devices, Others

➥ By Application: Diabetes, Obesity, Cardiovascular Diseases (CVD), Central Nervous System (CNS) Diseases, Respiratory Diseases, Smoking Cessation, Gastrointestinal Disorders (GID), Others

➥ By Sales Channel: Business-to-Business (B2B) (Employer, Healthcare Providers, Payers, Pharmaceutical Companies, Others), Business-to-Consumer (B2C) (Patient, Caregiver)

Research Process:

Both primary and secondary data sources have been used in the Digital Therapeutics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Most Frequently Asked Questions in the Digital Therapeutics Market Research Industry:

➠ Who leads the Digital Therapeutics industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do Digital Therapeutics market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting Digital Therapeutics market growth?
➠ What are the dominant sales and distribution strategies in the Digital Therapeutics industry?

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=digital-therapeutics-market

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.